Enzymatic and molecular modeling studies of 5-HT3 receptor ligands based on pyrroloquinoline structure and provided with acetylcholinesterase inhibitory activity

Medicinal Chemistry Research

Volumn 12, Issue 3, 2003, Pages 147-160

  Alcaro, Stefano ^a   Ortuso, Francesco ^a   Battaglia, Danilo ^a   Anzini, Maurizio ^b   Cappelli, Andrea ^b   Gallelli, Andrea ^b   Mohr, Galla Pericot ^b   Vomero, Salvatore ^b   Galli, Alessandro ^c   Costagli, Chiara ^c   Makovec, Francesco ^d  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d Rotta Research Laboratorium   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CHOLINESTERASE INHIBITOR; QUINOLINE DERIVATIVE; SEROTONIN 3 AGONIST; TACRINE;

ACETYLCHOLINE RELEASE; ARTICLE; CONCENTRATION RESPONSE; CONFORMATIONAL TRANSITION; CRYSTALLOGRAPHY; DEGRADATION; DRUG POTENCY; DRUG STRUCTURE; INHIBITION KINETICS; STRUCTURE ANALYSIS; THEORY;

EID: 0942268792     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Cutler, N. R.; Sramek, J. J. Review of the Next Generation of Alzheimer's Disease Therapeutics: Challenges for Drug Development. Prog. Neuropsychopharmacol. Biol. Psychiatry 2001, 25, 27-57.
2. 3 Receptor Ligands Based on the Pyrrolidone Structure: Synthesis, Biological Evaluation, and Computational Rationalization of the Ligand-Receptor Interaction Modalities. Bioorg. Med. Chem. 2002, 10, 779-801.
3. Wermuth, C. G. The "SOSA" approach: an alternative to high-throughoutput screening. Med. Chem. Res. 2001, 10, 431-439
4. Ellman, G. L.; Courtney, K. D.; Andres, V.; Featherstone, R. M. A New and Rapid Colorimetric Determination of Acetylcholinesterase Activity. Biochem. Pharmacol. 1961, 7, 88-95.
5. Harel, M.; Schalk, I.; Ehret-Sabatier, L.; Bouet, F.; Goeldner, M.; Hirth, C.; Axelsen, P. H.; Silman, I.; Sussman, J. L. Quaternary Ligand Binding to Aromatic Residues in the Active-Site Gorge of Acetylcholinesterase. Proc. Natl. Acad. Sci. USA. 1993, 90, 9031-5.
6. Alcaro, S.; Gasparrini, F.; Incani, O.; Mecucci, S.; Misiti, D.; Pierini, M.; Villani, C. A Quasi-Flexible Automatic Docking Processing for Studying Stereoselective Recognition Mechanisms. Part I. Protocol Validation. J. Comput. Chem. 2000, 21, 515-530.
7. Alcaro, S.; Scipione, L.; Ortuso, F.; Posca, S.; Rispoli, V.; Rotiroti, D. Molecular Modelling and Enzymatic Studies of the Interaction of a Choline Analogue and the Acetylcholinesterase. Bioorg. Med. Chem. Lett. 2002, 12, 0000
8. McDonald, D. Q.; Still, W. C. AMBER* Torsional Parameters for the Peptide Backbone, Tetrahedron Lett. 1992, 33, 7743-7746.
9. Still, W. C.; Tempczyk, A.; Hawley, R. C.; Hendrickson, T. Semianalytical Treatment of Solvation for Molecular Mechanics and Dynamics. J. Am. Chem. Soc. 1990, 112, 6127-6129.
10. The two distances have been selected respectively from the amide nitrogen attached in 3′ to the tropane moiety and oxygen of the phenolic group of Tyr121 e Tyr130. The filtering criterion accepted docking configurations with distances respectively lower than 9.5 and 11 Å.
11. Andreani, A.; Cavalli, A.; Granaiola, M.; Guardigli, M.; Leoni, A.; Locatelli, A.; Morigi, R.; Rambaldi, M.; Recanatini, M. and Roda, A. Synthesis and Screening for Antiacetylcholinesterase Activity of (1-Benzyl-4-oxopiperidin- 3-ylidene) methylindoles and -pyrroles Related to Donepezil. J. Med. Chem. 2001, 44, 4011-4014.
12. Kryger, G.; Silman, I; Sussman, L.; Structure of Acetylcholinesterase Complexed with E2020 (Aricept): Implications for the Design of New Anti-Alzheimer Drugs. Structure 1999, 7, 297-307.